Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Comparision between Esteem Bio IPO and HPC Biosciences IPO.
Esteem Bio IPO is a SME Fixed Price Issue IPO proposed to list at BSE SME while HPC Biosciences IPO is a SME Fixed Price Issue proposed to list at BSE SME.
| Esteem Bio IPO | HPC Biosciences IPO | |
|---|---|---|
| Logo |  |
 |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price Issue | Fixed Price Issue |
| Listing At | BSE SME | BSE SME |
| Lead Managers | Oneview Corporate Advisors Pvt. Ltd. | Oneview Corporate Advisors Pvt. Ltd. |
| Registrar | Cameo Corporate Services Limited | Cameo Corporate Services Limited |
| Market Maker | Guiness Securities Limited | Narayan Securities Limited |
| DRHP | DRHP  |
DRHP |
| RHP | RHP |
RHP |
| Anchor Investor | ||
| IPO Allotment URL |
The total issue size of Esteem Bio IPO is up to ₹11.25 Cr whereas the issue size of the HPC Biosciences IPO is up to ₹15.75 Cr. The final issue price of Esteem Bio IPO is ₹25.00 per share and of HPC Biosciences IPO is ₹35.00 per share.
| Esteem Bio IPO | HPC Biosciences IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹25.00 per share | ₹35.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 6000 shares | 4000 shares |
| Fresh Issue Size | ||
| Fresh Issue Size (Amount) | ||
| OFS Issue Size | ||
| OFS Issue Size (Amount) | ||
| Issue Size Total | 45,00,000 shares | 45,00,000 shares |
| Issue Size Total (Amount) | up to ₹11.25 Cr | up to ₹15.75 Cr |
Esteem Bio IPO opens on Jan 18, 2013, while HPC Biosciences IPO opens on Mar 01, 2013. The closing date of Esteem Bio IPO and HPC Biosciences IPO is Jan 22, 2013, and Mar 05, 2013, respectively.
| Esteem Bio IPO | HPC Biosciences IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Jan 18, 2013 | Mar 01, 2013 |
| Issue Close | Jan 22, 2013 | Mar 05, 2013 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | ||
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Esteem Bio IPO P/E ratio is , as compared to HPC Biosciences IPO P/E ratio of .
| Esteem Bio IPO | HPC Biosciences IPO | |
|---|---|---|
| Financial | ||
| Promoter Shareholding (Pre-Issue) | 29.51% | 30.69% |
| Promoter Shareholding (Post-Issue) | 25.63% | 22.01% |
| P/E Ratio | ||
| Market Cap | ||
| ROE | ||
| ROCE | ||
| Debt/Equity | ||
| EPS | ||
| RoNW | 34.38%% | 63.53%% |
In the Esteem Bio IPO retail investors (RII) are offered while in HPC Biosciences IPO retail investors are offered . Qualified institutional buyers (QIB) are offered in Esteem Bio IPO and in HPC Biosciences IPO.
| Esteem Bio IPO | HPC Biosciences IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | 7,50,000 shares | 2,32,000 shares |
| QIB | ||
| NII | ||
| RII | ||
| Employee | ||
| Others | ||
| Total |
Esteem Bio IPO subscribed in total, whereas HPC Biosciences IPO subscribed .
| Esteem Bio IPO | HPC Biosciences IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | ||
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | ||
| Employee (times) | ||
| Other (times) | ||
| Total (times) |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
